Symbotic Inc vs Tilray Brands Inc — how do they compare? Symbotic Inc trades at $41 (market cap $5.41B), while Tilray Brands Inc trades at $4.67 (market cap $649.42M). The key difference: Symbotic Inc is far larger — about 8.3× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.
| SYM | TLRY | |
|---|---|---|
Market Cap | $5.41B | $649.42M |
Sector | Technology | Health |
52-Week High | $87.30 | $21.00 |
52-Week Low | $38.57 | $3.88 |
Enterprise Value | $3.67B | $816.55M |
Signals from Pluang's Aura AI — not financial advice
SYM trades at $41.17, up 2.64% today but facing bearish technical signals with 15 sell indicators. The company reported mixed Q3 2026 results with revenue growth of 21.7% but an earnings miss. Despite negative net income of -$16.94M in 2025, cash flow remains strong at $516.84M and analysts maintain a $60 consensus target with 61% buy ratings.
SYM presents a growth story with expanding revenue and margin improvements, but faces execution risks amid recent earnings misses. The stock offers potential upside to analyst targets but requires careful monitoring of profitability trends and competitive pressures in the warehouse automation sector.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Trailing returns across standard periods
Latest headlines on both assets
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →